Healthpeak Properties (NYSE:DOC) Stock Price Expected to Rise, Scotiabank Analyst Says

Healthpeak Properties (NYSE:DOC) had its target price upped by Scotiabank from $19.00 to $21.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “sector perform” rating on the real estate investment trust’s stock. Scotiabank’s price target would indicate a potential upside of 4.19% from the stock’s previous close.

DOC has been the topic of several other reports. UBS Group boosted their price objective on shares of Healthpeak Properties from $17.00 to $19.00 and gave the company a “neutral” rating in a research note on Wednesday, May 13th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a report on Sunday, May 10th. Royal Bank Of Canada raised their price objective on shares of Healthpeak Properties from $20.00 to $21.00 and gave the company an “outperform” rating in a research report on Thursday, May 14th. Finally, Argus lowered Healthpeak Properties from a “buy” rating to a “hold” rating in a report on Thursday, February 5th. Five investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $19.23.

Healthpeak Properties Stock Performance

DOC traded up $0.13 on Wednesday, hitting $20.16. 617,638 shares of the company traded hands, compared to its average volume of 8,920,160. Healthpeak Properties has a 12-month low of $15.70 and a 12-month high of $20.27. The company has a 50 day moving average of $17.61 and a 200-day moving average of $17.29. The company has a quick ratio of 2.96, a current ratio of 2.96 and a debt-to-equity ratio of 1.15. The stock has a market capitalization of $13.90 billion, a PE ratio of 62.88, a PEG ratio of 2.51 and a beta of 1.00.

Healthpeak Properties (NYSE:DOC) last announced its earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. Healthpeak Properties had a return on equity of 2.61% and a net margin of 7.73%.The company had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. During the same period last year, the business posted $0.46 EPS. The company’s revenue was up 7.1% on a year-over-year basis. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Sell-side analysts anticipate that Healthpeak Properties will post 1.75 earnings per share for the current year.

Insider Transactions at Healthpeak Properties

In other news, insider Scott R. Bohn sold 10,989 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider owned 7,636 shares of the company’s stock, valued at $148,520.20. The trade was a 59.00% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Healthpeak Properties

Several hedge funds and other institutional investors have recently bought and sold shares of DOC. Argent Advisors Inc. purchased a new position in shares of Healthpeak Properties during the 3rd quarter worth approximately $1,536,000. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Healthpeak Properties by 7.0% during the 3rd quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,935,397 shares of the real estate investment trust’s stock valued at $37,063,000 after buying an additional 126,322 shares during the last quarter. Twin City Private Wealth LLC purchased a new position in Healthpeak Properties during the third quarter worth $1,148,000. JPMorgan Chase & Co. increased its position in Healthpeak Properties by 41.0% during the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock worth $540,730,000 after buying an additional 8,212,504 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its holdings in shares of Healthpeak Properties by 8.4% in the third quarter. Bank of New York Mellon Corp now owns 6,754,147 shares of the real estate investment trust’s stock worth $129,342,000 after acquiring an additional 525,875 shares during the last quarter. 93.57% of the stock is owned by institutional investors and hedge funds.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.